Gilead says remdesivir coronavirus treatment reduces risk of death

Gilead Sciences announced new findings Friday that its antiviral drug remdesivir reduced the risk of death for severely sick coronavirus patients by 62% compared with standard care alone, saying more research is needed. The company said its analysis also found that...

Opening and closing may be death knell for restaurants

Junior’s Cheesecake owner Alan Rosen told CNBC on Monday that restaurants would be in serious financial trouble if they have to reopen then close back down due to the coronavirus pandemic.  “This opening and closing could be the death knell of restaurants...